CENTER ID: | BobuA.19118.a |
ORGANISM: | Borrelia burgdorferi B31 |
ASSOCIATED DISEASE: | Lyme disease |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
I |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
BobuA.19118.a.B2.GE40459 | soluble domain #1 | 1 | 142 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
BobuA.19118.a.B2.PW37961 | soluble domain #1 | 1 | 142 |
RESOURCE | REFERENCE ID |
---|---|
BV-BRC: | fig|224326.49.peg.480 |
RefSeq: | NP_212216.1 |
UniProt: | O51109 |
HARVESTED ON: | 8/10/2016 |
SEQUENCED ON: | 8/11/2016 |
EXPECTED MW: | 18kDa |
OBSERVED MW: | 18kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Low Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
PURIFICATION DATe: | 11/1/2016 |
CONCENTRATION: | 28mg/ml |
OBSERVED MW: | 17kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 4 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |